Eli Lilly builds $1.5B stockpile of weight loss pills ahead of FDA approval
Eli Lilly has stockpiled approximately $1.5 billion worth of “pre-launch inventory” for its investigational weight loss pill orforglipron, in advance of regulatory approval by the U.S. Food and Drug Administration (FDA), according to the drugmaker’s 2025 …